In May 2024, Recursion Pharmaceuticals unveiled BioHive-2, a 504-GPU supercomputer it called the largest in the pharmaceutical industry. Nearly two years later, Roche claims to have almost seven times that number, and none of the companies in this emerging GPU arms race has publicly tied a specific clinical candidate to its AI infrastructure. Roche deployed…